NCT07055906 Video-feedback Intervention to Promote Racial-Ethnic Socialization Competency (VIP-RACE)
| NCT ID | NCT07055906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Penn State University |
| Condition | Depressive Symptoms |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2025-05-12 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2025-05-12 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate a novel cultural strengths parenting program - the Video-feedback Intervention to Promote Racial-Ethnic Socialization CompEtency (VIP-RACE) - which seeks to support Latine parents' motivation to engage in racial-ethnic socialization (RES) and strengthen their RES competency (improved skills and confidence, decreased stress). In the preliminary phases of this project, we iteratively refined the VIP-RACE program in partnership with advisory boards of youth, parents, and providers. The refined intervention will now be tested with five parents of 10-14-year-old Latine youth to identify gaps in the curriculum and obstacles to implementation that can be addressed prior to a larger pilot. The investigators will then conduct a proof-of-concept single-arm trial with Latine families to assess the feasibility, acceptability, and preliminary efficacy of VIP-RACE. The investigators hypothesize that VIP-RACE will be shown to be feasible and acceptable to families. The investigators also predict that bolstering parents' RES motivation and competency will result in increased frequency and quality of these conversations between parents and youth which, in turn, are expected to strengthen youth racial-ethnic identity and coping and have cascading effects on mental and behavioral health.
Eligibility Criteria
Inclusion Criteria: * Adolescent is 10-to-14 years old (inclusive) * Adolescent and parent are Latino/a/x/e or Hispanic * Parent and youth have the capacity to provide consent/assent * One parent is willing to participate * Families must be willing to be video or audio recorded for the parent-child interaction task * Youth and parent(s) must be willing to participate as dyads. * Primary language of parent and adolescent is English and/or Spanish Exclusion Criteria: * Parent or adolescent has an intellectual disability, autism spectrum disorder, or other disorder that may limit ability to complete study (surveys and interviews require sustained attention, mental processing, and comprehension). * Adolescent is not 10-to-14 years old * Adolescent and/or parent are not Latino/a/x/e or Hispanic * Primary language of parent and/or adolescent is not English and/or Spanish * Youth and parent(s) are not willing to participate as dyads * Family participated in Phase 1 of the study
Contact & Investigator
Principal Investigator
PRINCIPAL INVESTIGATOR
The Pennsylvania State University
Frequently Asked Questions
Who can join the NCT07055906 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 14 Years, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07055906 currently recruiting?
Yes, NCT07055906 is actively recruiting participants. Contact the research team at cag6443@psu.edu for enrollment information.
Where is the NCT07055906 trial being conducted?
This trial is being conducted at Harrisburg, United States.
Who is sponsoring the NCT07055906 clinical trial?
NCT07055906 is sponsored by Penn State University. The principal investigator is Principal Investigator at The Pennsylvania State University. The trial plans to enroll 110 participants.